Conference paper

Stabile remission of early active rheumatoid arthritis treated with etanercept (Enbrel®)

Dušanka Martinović Kaliterna ; Department for Clinical Immunology and Rheumatology, Clinic for Internal Medicine, Clinical Hospital Centre Split, Split, Croatia

Abstract

Regarding to the role of cytokines in ethiology of rheumatoid arthritis, the treatment with anti-TNFα is coming to be reasonable in early aggressive rheumatoid arthritis. Studies of etanercept in early stage of disease indicate the sustained efficacy and decreased rate of radiographic progression with signifficant improvement of life quality.

Keywords

rheumatoid arthritis; anti-TNFα; etanercept

Hrčak ID:

125247

URI

https://hrcak.srce.hr/125247

Publication date:

17.10.2008.

Article data in other languages: croatian

Visits: 1.080 *